Silexion Therapeutics Corp (SLXN) — Dilution Risk Analysis

Current Snapshot

Silexion Therapeutics Corp (SLXN) has a DilutionWatch score of 90/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
5,560,256 Source
Public Float
414,767 Source
Float as % of Outstanding
7.5%

Dilution Risk Score

Score: 90/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: EFFECT 1, 4 9.

FormFiledAccession
EFFECT 2026-08-11 9999999995-26-002627
4 2026-03-30 0001178913-26-001858
4 2026-02-25 0001178913-26-000644
4 2026-02-23 0001178913-26-000594
4 2026-02-23 0001178913-26-000596
4 2026-02-23 0001178913-26-000598
4 2026-02-23 0001178913-26-000600
4 2026-02-23 0001178913-26-000602
4 2026-02-23 0001178913-26-000604
4 2026-02-23 0001178913-26-000606

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 2 months Source
Three-year share count growth 671.0% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 90/10) Source
Cash Runway
2 months Source
Share Count Growth (3-Year)
671.0% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.